ASHLAND, Mass., March 14, 2025 /PRNewswire/ -- BioSurfaces, a leader in advanced nanofiber materials, and Morphocell Technologies, a regenerative medicine company, are pleased to announce a ...

BioSurfaces has received a $2.06m one-year grant from the Bill & Melinda Gates Foundation to further the development of its Bio-Spun Cell Chamber (BSCC) device. The device encapsulates cells that are ...

BioSurfaces, a company focused on improving lives throughout the world, announced that the company has been awarded a $2.06 million grant from the Bill & Melinda Gates Foundation. This one-year grant ...

CAMBRIDGE & ASHLAND, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) and BioSurfaces Inc. announced today that they have entered into an agreement to initiate a research ...

Takeda and BioSurfaces entered into a joint research program aimed at developing new medical devices for gastrointestinal diseases. 1. The venture will focus on BioSurfaces’ nanomaterial technology, ...

Takeda and BioSurfaces have signed an agreement to develop medical devices for the treatment of gastrointestinal diseases. The Japanese pharma will contribute its gastroenterology know-how, while the ...

Biosurfaces are synthetic surfaces that are coated with biological materials and/or are designed to have a specific biological function or application. They are important in areas such as sensing and ...

Biomedical device maker BioSurfaces Inc. of Ashland has been named the state’s Microenterprise of the Year for 2015. The award was announced Monday by the Massachusetts office of the U.S. Small ...